NCT05337241 - Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

August 9, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Refractory Ventricular Tachycardia

Interventions

DEVICE

Saline Enhanced Radiofrequency (SERF) Ablation

The Durablate intramural needle catheter delivers heated saline to target tissue in the left ventricle to target mid-myocardial and epicardial VT substrates

Trial Locations (7)

19104

NOT_YET_RECRUITING

Hospital of the University of Pennsylvania, Philadelphia

29425

NOT_YET_RECRUITING

Medical University of South Carolina, Charleston

35233

NOT_YET_RECRUITING

University of Alabama at Birmingham, Birmingham

37232

NOT_YET_RECRUITING

Vanderbilt University Medical Center, Nashville

84124

RECRUITING

Intermountain Healthcare, Salt Lake City

H1T 1C8

RECRUITING

Montreal Heart Institute - Institut de Cardiologie de Montréal, Montreal

Unknown

NOT_YET_RECRUITING

Quebec Heart and Lung Institute - Institut universitaire de cardiologie et de pneumologie de Québec, Québec

All Listed Sponsors

lead

Thermedical, Inc.

INDUSTRY